首页> 外国专利> CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF 14-3-3, FUSICOCCIN, AND PLASMA MEMBRANE ATPASE AND METHODS FOR DESIGNING NEW HERBICIDES

CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF 14-3-3, FUSICOCCIN, AND PLASMA MEMBRANE ATPASE AND METHODS FOR DESIGNING NEW HERBICIDES

机译:14-3-3,FUSICOCCIN和血浆膜ATPase三元配合物的晶体结构及新除草剂的设计方法

摘要

The present invention relates to a crystal of a ternary complex composed of the protein 14-3-3, a ligand thereof and a fragment of Plasma Membrane ATPase (PMA) comprising the coordinates of table 4 or coordinates which differ from the coordinates of table 4 by a root mean square deviation of the C-alpha atoms of less than 3 Angstrom, wherein (a) protein 14-3-3 consists of the amino acid sequence of SEQ ID NO: 1 or of the sequence of a species homolog; (b) the ligand is Fusicoccin; (c) PMA is a C-terminal peptide of up to 15 amino acid residues in 'length; comprising the amino acid sequence of SEQ ID NO: 2 or comprising the sequence of a species homolog. Moreover, the invention also relates to methods for obtaining crystals of 14-3-3 in ternary complex and to methods relating to the determination of said 14-3-3 crystal coordinates. In addition, the present invention relates to computer modeling of crystal coordinates, to methods for developing a ligand binding to the complex of protein 14-3-3 and PMA and to methods for identifying a potential ligand to the complex of 14-3-3 and PMA. Furthermore, the present invention relates to a method for identifying and selecting a protein or protein complex with increased affinity to a ligand, to nucleic acid molecules encoding PMA or 14-3-3 with decreased affinity to a ligand and to methods of generating transgenic plants encoding PMA or 14-3-3 with decreased affinity to said ligand. Finally, the present invention relates to a device for developing a ligand for the complex of PMA and 14-3-3 and to the use of said device.
机译:本发明涉及由蛋白质14-3-3,其配体和血浆膜ATP酶(PMA)的片段组成的三元复合物的晶体,其包含表4的坐标或与表4的坐标不同的坐标。 C-α原子的均方根偏差小于3埃,其中(a)蛋白14-3-3由SEQ ID NO:1的氨基酸序列或物种同源物的序列组成; (b)配体为岩藻球蛋白; (c)PMA是一个C末端肽,其长度最多为15个氨基酸残基;包含SEQ ID NO:2的氨基酸序列或包含物种同源物的序列。此外,本发明还涉及用于获得三元络合物的14-3-3晶体的方法,并且涉及与确定所述14-3-3晶体坐标有关的方法。另外,本发明涉及晶体坐标的计算机建模,用于开发与蛋白质14-3-3和PMA的复合物结合的配体的方法以及用于鉴定与14-3-3的复合物的潜在配体的方法。和PMA。此外,本发明涉及用于鉴定和选择对配体的亲和力增加的蛋白质或蛋白质复合物的方法,对配体的亲和力降低的编码PMA或14-3-3的核酸分子以及产生转基因植物的方法。编码对所述配体具有降低的亲和力的PMA或14-3-3。最后,本发明涉及用于开发PMA和14-3-3的复合物的配体的装置以及该装置的用途。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号